Semaglutide and Weight Reduction
Semaglutide, a medication initially developed to manage diabetes, has revealed possible as a weight-loss help. It works by reducing hunger, therefore decreasing caloric consumption. The normal dosage for weight reduction is administered weekly.In a phase 3 scientific trial performed in 2021, it was found that administering a weekly 2.4 milligram dose of Semaglutide resulted in notable weight reduction.
Wegovy: The First Once-Weekly Treatment
Under the brand Wegovy, Semaglutide has received FDA approval for the long-term management of weight. This medication, which is taken as soon as a week, is the very first in its class to be authorized by the FDA for chronic weight management.While the drug can aid in weight loss, it needs to be utilized together with changes to diet and exercise for the very best outcomes. The FDA suggests losing 5% to 10% of body weight through diet and exercise as it can have significant health advantages.